Mile High 420: The world’s largest cannabis festival gets lit

Published 05-APR-2019 15:40 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Stoners unite - it’s that time of the year again.

On April 20, pot enthusiasts from around the world will head to Colorado to partake in the annual Mile High 420 festival. As the first state to legalise cannabis, Colorado has a unique history with the marijuana movement.

The event, which takes place at Denver’s Civic Center Park, sees over 50,000 people enjoy the free entertainment and assortment of food and beverage options on offer.

This year’s rendition promises to be a fresh take on the popular gathering, with emerging cannabis company, Golden Developing Solutions Inc. (OTCMKTS:DVLP), announcing the launch of its first annual 420 shared festival at the Mile High event.

“In a sense, the whole cannabis culture ultimately wants to come together to share the 420 festival experience,” DVLP CEO Stavros Triant said.

“We will be in Denver along with 75 thousand other enthusiasts, but all across the county on 4/20, there will be smaller festivals with several hundred to several thousand participants.

“We have been aggressively reaching out to the organisers of these festivals, and they are extremely enthusiastic about the idea of connecting up with us at Mile High for a shared experience,” he said.

The launch of the shared festival is a major coup for DVLP, which is developing a leading online retail marketplace for cannabis, CBD, hemp oil and vaping products.

It has recruited more than 12 different festivals to participate in the upcoming shared festival event.

“Virtually every single organiser we have contacted has immediately jumped at the chance to join our event.

“And we have a long list of additional organisers to contact over the next three weeks. The scale of the event has grown since our initial conception.

“Not only will this serve as an extremely strong platform for brand awareness for our CBD franchise, but it will also give us a potent vehicle to further accelerate our Where’s Weed brand in the locator space,” Triant added.

More about the Mile High bender

American artists T.I. and Jermaine Dupri will headline this year’s festival.

Gates open at 10am and close at 6pm – entry is free.

Escape Artists, Penvape and High Country Cones are just some of the leading sponsors in 2019.

Ironically, despite the theme attendees are not permitted to consume cannabis on site.

Why? Despite recreational cannabis being legal in the state of Colorado, public consumption is illegal. Civic Center Park is recognised as a city-owned property and is therefore deemed as public land.

It’s not yet known if attendees will be permitted to rip a fat J on site this year, but according to reports public pot smoking was not lodged in the event permit application to the City and County of Denver.

Denver-region dispensary franchise Euflora will again host this year’s edition, after taking over from long-time organiser Miguel Lopez in 2018.

Lopez and his entourage were stripped of their hosting privileges in 2016 when long queues led to frustrated pot goers breaking down a perimeter fence, in what can only be described as an attack of the munchies.

Two people were taken into custody as hundreds of people poured into the festival unchecked by security.

For more information on Mile High 420 Festival, click here.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X